Corteva, Inc. $CTVA Shares Purchased by Handelsbanken Fonder AB

Handelsbanken Fonder AB grew its stake in shares of Corteva, Inc. (NYSE:CTVA) by 7.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 402,845 shares of the company’s stock after acquiring an additional 28,517 shares during the quarter. Handelsbanken Fonder AB’s holdings in Corteva were worth $27,003,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of CTVA. Northwestern Mutual Wealth Management Co. increased its holdings in shares of Corteva by 6,527.4% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,148,212 shares of the company’s stock valued at $211,025,000 after acquiring an additional 3,100,709 shares in the last quarter. Perpetual Ltd increased its holdings in shares of Corteva by 78,688.5% during the fourth quarter. Perpetual Ltd now owns 2,615,779 shares of the company’s stock valued at $175,336,000 after acquiring an additional 2,612,459 shares in the last quarter. Amundi increased its holdings in shares of Corteva by 125.3% during the third quarter. Amundi now owns 3,415,554 shares of the company’s stock valued at $219,620,000 after acquiring an additional 1,899,248 shares in the last quarter. Squarepoint Ops LLC increased its holdings in Corteva by 423.6% in the 3rd quarter. Squarepoint Ops LLC now owns 1,738,139 shares of the company’s stock worth $117,550,000 after buying an additional 1,406,199 shares during the period. Finally, Man Group plc increased its holdings in Corteva by 16,474.3% in the 3rd quarter. Man Group plc now owns 1,294,125 shares of the company’s stock worth $87,522,000 after buying an additional 1,286,317 shares during the period. Institutional investors and hedge funds own 81.54% of the company’s stock.

Insider Activity at Corteva

In other news, insider Brian Titus sold 8,311 shares of the firm’s stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the sale, the insider owned 8,090 shares of the company’s stock, valued at $619,289.50. This trade represents a 50.67% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.15% of the stock is owned by insiders.

Analysts Set New Price Targets

CTVA has been the topic of several research reports. Wall Street Zen downgraded shares of Corteva from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Citigroup increased their price target on shares of Corteva from $83.00 to $85.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. Zacks Research downgraded shares of Corteva from a “strong-buy” rating to a “hold” rating in a report on Friday, February 20th. Royal Bank Of Canada increased their price target on shares of Corteva from $95.00 to $97.00 and gave the stock an “outperform” rating in a report on Thursday, May 7th. Finally, Mizuho increased their price target on shares of Corteva from $82.00 to $94.00 and gave the stock an “outperform” rating in a report on Wednesday, April 15th. Thirteen research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $88.14.

Corteva Price Performance

Shares of NYSE CTVA opened at $78.77 on Thursday. The stock has a market capitalization of $52.68 billion, a price-to-earnings ratio of 46.33, a PEG ratio of 2.42 and a beta of 0.59. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $85.63. The firm’s 50 day simple moving average is $81.25 and its 200-day simple moving average is $73.79. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. The business had revenue of $4.91 billion for the quarter, compared to analysts’ expectations of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business’s revenue was up 11.0% on a year-over-year basis. During the same quarter last year, the company earned $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Analysts expect that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be paid a dividend of $0.18 per share. The ex-dividend date of this dividend is Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is presently 42.35%.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.